bioAffinity Technologies (BIAF) Asset Utilization Ratio (2023 - 2026)

bioAffinity Technologies (BIAF) has reported Asset Utilization Ratio for 4 consecutive years, with 0.6 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 59.01% year-over-year to 0.6; the TTM figure through Mar 2026 stood at 0.6 (down 59.01% YoY), while the FY2025 annual figure was 0.71, down 44.5% from the prior year.
• Asset Utilization Ratio rose to 0.6 in Q1 2026 per BIAF's latest filing, from 0.55 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.49 in Q2 2025 and bottomed at 0.0 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 0.75 across 4 years, with a median of 0.61 in 2024.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 119993.65% — and 2025, when it tumbled 61.79%.
• bioAffinity Technologies' Asset Utilization Ratio stood at 0.28 in 2023, then surged by 420.91% to 1.43 in 2024, then sank by 61.79% to 0.55 in 2025, then increased by 9.35% to 0.6 in 2026.
• Business Quant data shows BIAF's Asset Utilization Ratio at 0.6 in Q1 2026, 0.55 in Q4 2025, and 0.83 in Q3 2025.